We are conducting market research on ADC Interoperability and are looking to speak to people diagnosed with type 1 or type 2 diabetes who are currently receiving multiple daily injection insulin therapy (with or without other anti-diabetes medication on the matter. To take part in this study, that will take form of a web-assisted telephone interview lasting 45 minutes and include a 15 minute pre task please click on the button below.
Les fiers membres et tenants de:
